Other benign neoplasm of skin of left lower eyelid, including canthus
ICD-10 D23.122 is a billable code used to indicate a diagnosis of other benign neoplasm of skin of left lower eyelid, including canthus.
D23.122 refers to a benign neoplasm located on the skin of the left lower eyelid, including the canthus, which is the corner of the eye where the upper and lower eyelids meet. Benign neoplasms in this area can include a variety of skin lesions such as seborrheic keratosis, dermatofibromas, or other non-cancerous growths. These lesions are typically asymptomatic but may cause cosmetic concerns or irritation. Diagnosis is usually made through clinical examination, and in some cases, a biopsy may be performed to confirm the benign nature of the lesion. Management often involves monitoring the lesion for changes, and if necessary, surgical excision may be performed for cosmetic reasons or if the lesion becomes symptomatic. Follow-up care is essential to ensure that the lesion does not recur or change in character, which could necessitate further evaluation.
Detailed description of the lesion, including size, color, and texture; photographic evidence may be beneficial.
Evaluation of a patient presenting with a new skin lesion on the eyelid; follow-up after excision of a benign lesion.
Ensure that the diagnosis is clearly documented as benign and specify the type of neoplasm.
Comprehensive eye examination findings, including visual acuity and any impact on eyelid function.
Management of eyelid lesions affecting vision or causing discomfort; surgical intervention for cosmetic reasons.
Document any functional impairment caused by the lesion, as this may influence treatment decisions.
Used when a benign neoplasm on the left lower eyelid is excised.
Document the size and type of lesion, as well as the excision details.
Ensure that the excision is documented as medically necessary and that the lesion is confirmed as benign.
Accurate coding of D23.122 is crucial for proper reimbursement, tracking of benign skin lesions, and ensuring appropriate patient management. It helps in distinguishing benign from malignant conditions, which is essential for treatment planning.
